Clinical TrialsSearch results
Number of results: 678
Not yet recruiting
- A study of treatment of peripheral neuropathy with MSC-CM
- Peripheral neuropathy
- Kimura Shin
- 2024-05-07
Not yet recruiting
- A study of treatment of chronic pain with MSC-CM
- Chronic Pain
- Sugawara Kou
- 2024-04-03
Not yet recruiting
- A Study of JNJ-68284528 Out - of - Specification (OOS) for Commercial Release in Participants with Multiple Myeloma
- Multiple Myeloma
- Fujikawa Ei
- 2023-01-30
Not yet recruiting
- A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis
- idiopathic pulmonary fibrosis
- Kanmuri Kazuhiro
- 2024-05-07
Not yet recruiting
- A prospective study on the efficacy and safety of double stenting with a narrow covered self-expandable metallic stent (SEMS) for malignant distal bile duct stenosis
- obstructive jaundice
- Shiomi Hideyuki
- 2022-01-22
Not yet recruiting
- A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Alzheimer Disease
- Wakayama Naohiko
- 2024-04-03
Other
- Z-206 Phase III Clinical Trial -Investigation on the remission–maintaining effect in patients with Crohn's disease in remission phase-
- Patients with Crohn's disease in remission phase
- Zeria Pharmaceutical Co.,LTD.
- 2005-12-22
Other
- Z-206 Phase III Clinical Trial - Investigation on the remission-maintaining effect in patients with ulcerative colitis in remission phase -
- Patients with ulcerative colitis in remission phase.
- Zeria Pharmaceutical Co.,LTD.
- 2005-11-21
Other
- Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with ulcerative colitis in active phase -
- Patients with ulcerative colitis in active phase
- Zeria Pharmaceutical Co.,LTD.
- 2005-11-21
Other
- Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with Crohn's disease in active phase -
- Patients with Crohn's disease in active phase
- Zeria Pharmaceutical Co.,LTD
- 2005-12-22